Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
15 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250715864575/en/Enanta-Pharmaceuticals-to-Participate-in-Bairds-Biotech-Discovery-Series
12 Jun 2025
// PRESS RELEASE
https://news.abbvie.com/2025-06-11-U-S-FDA-Approves-Expanded-Indication-for-AbbVies-MAVYRET-R-Glecaprevir-Pibrentasvir-as-First-and-Only-Treatment-for-People-with-Acute-Hepatitis-C-Virus
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527817221/en/Enanta-Pharmaceuticals-to-Present-at-the-Jefferies-Global-Healthcare-Conference
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522937132/en/Enanta-Pharmaceuticals-Announces-Data-from-its-Phase-2-Study-of-Zelicapavir-in-Children-with-Respiratory-Syncytial-Virus-to-be-Presented-at-the-43rd-Annual-ESPID-Meeting
12 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250512968099/en/Enanta-Pharmaceuticals-Reports-Financial-Results-for-its-Fiscal-Second-Quarter-Ended-March-31-2025
08 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250408012708/en/Enanta-Pharmaceuticals-Announces-Respiratory-Syncytial-Virus-Data-Presentation-at-ESCMID-Global-2025
ABOUT THIS PAGE